Response, Partial Response, and Nonresponse in Primary Care Treatment of Depression
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Depressive disorders are one of the most common reasons for visits to primary care physicians. This study identifies factors related to poor response to depression treatment with selective serotonin reuptake inhibitors (SSRIs) in primary care settings by (1) examining clinical response taking into account treatment, (2) comparing baseline characteristics and outcomes between patients classified by response, and (3) examining characteristics predicting poor response. METHODS: A Randomized Trial Investigating SSRI Treatment (ARTIST) was a prospective naturalistic trial comparing effectiveness of SSRI therapy. Eligible patients were randomized to treatment (N = 601) and followed up for 9 months. Treatment patterns were classified as "adequate" (6-month continuous medication), "aggressive" (defined by a treatment algorithm), or "inadequate" (discontinuations) by patient-reported medication use. Clinical response was determined by use of the Symptom Checklist-20 (SCL-20), with patients classified as remitters (score < or =6), partial remitters (50% decrease in symptoms), or nonresponders. Groups were compared on baseline characteristics, functioning, and treatment patterns. Multinomial logistic regression was used to determine predictors of response. RESULTS: Of patients completing 6-month evaluations (n = 482), 46% were classified as nonresponders. Additionally, 53% (n = 256) received adequate therapy but did not achieve remission and 13% (n = 61) had aggressive therapy associated with treatment resistance. Significant predictors of nonresponse included older age, diagnosis, worse physical functioning, and lower energy level. CONCLUSIONS: A substantial number of adequately treated patients did not respond to antidepressant therapy. Some of these patients may be considered undertreated or treatment-resistant according to current treatment guidelines recommending dose increases or medication switches for less than adequate clinical response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jacobson, N. S., & Truax, P. (1991) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.59.1.12 · Cited by 7,770
Measuring Functioning and Well-Being: The Medical Outcomes Study Approach
Stewart, A., & Ware, J. (1992) · doi:10.7249/cb361 · Cited by 2,689
Wells, K. B., Sherbourne, C., Schoenbaum, M., Duan, N., Meredith, L., Unützer, J., Miranda, J., Carney, M. F., & Rubenstein, L. V. (2000) · JAMA · doi:10.1001/jama.283.2.212 · Cited by 1,021 · cited 1×
“time, and to adhere to published treatment guidelines in response to observed treatment responses.(5,35) Providing methods for monitoring patient outcomes (eg, automated systems to collect patient reported symptom severity) may provide an efficient mechanism for PCPs to receive needed outcomes data in order to provide…”
MethodA Multifaceted Intervention to Improve Treatment of Depression in Primary Care
Katon, W. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830100072009 · Cited by 835 · cited 2×
“The SCL-20 (a modified subscale of the Hopkins Symptom Checklist and Brief Symptom Inventory) has been successfully used in a number of primary care depression trials in which it has demonstrated ability to detect changes in depression severity between treatment groups.(5,8,16) Secondary outcomes included additional d…”
MethodCase-Finding Instruments for Depression in Primary Care Settings
Mulrow, C. D., Williams, J. W., Gerety, M. B., Ramirez, G., Montiel, O. M., & Kerber, C. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-122-12-199506150-00004 · Cited by 456
Rudolph, R. L., & Feiger, A. D. (1999) · Journal of Affective Disorders · doi:10.1016/s0165-0327(99)00067-1 · Cited by 158
Dieric, M., Ravizza, U., Realini, R., & Martin, A. (1996) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(95)00292-8 · Cited by 152
Collaborative Management to Achieve Treatment Guidelines: Impact on Depression in Primary Care
Katon, W. (1995) · JAMA · doi:10.1001/jama.1995.03520370068039 · Cited by 6
Cited by
Defining and Measuring Functional Recovery from Depression
Greer, T. L., Kurian, B. T., & Trivedi, M. H. (2010) · CNS Drugs · doi:10.2165/11530230-000000000-00000 · Cited by 222
Carter, G. C., Cantrell, R. A., Zarotsky, V., Haynes, V. S., Phillips, G., Alatorre, C. I., Goetz, I., Paczkowski, R., & Marangell, L. B. (2012) · Depression and Anxiety · doi:10.1002/da.21918 · Cited by 109
Hengartner, M. P., & Plöderl, M. (2022) · BMJ Evidence-Based Medicine · doi:10.1136/bmjebm-2020-111600 · Cited by 114
Romera, I., Perez, V., Menchón, J. M., Delgado-Cohen, H., Polavieja, P., & Gilaberte, I. (2010) · European Psychiatry · doi:10.1016/j.eurpsy.2009.02.007 · Cited by 91
“The persistence of PR has been associated with an increased risk of relapse [23], shorter time to relapse [13], poorer quality of life [2,4] and disability [4].”
BackgroundEffects of serum brain derived neurotrophic factor on exercise augmentation treatment of depression.
Toups, M. S. P., Greer, T. L., Kurian, B. T., Grannemann, B. D., Carmody, T. J., Huebinger, R., Rethorst, C., & Trivedi, M. H. (2011) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2011.05.002 · Cited by 85
“Several pharmacological and non-pharmacological treatments are available for Major Depressive Disorder (MDD); however, only about one-third of patients achieve remission following initial treatment (Corey-Lisle et al., 2004; Trivedi et al., 2006c).”
Background
Metadata
- Authors
- Corey-Lisle, P. K., Nash, R., Stang, P., & Swindle, R.
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2004-06-14
- Volume
- 164
- Issue
- 11
- Pages
- 1197
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W1984168485
- Cited by
- 106
- References
- 8
- FWCI
- 4.30
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Response, Partial Response, and Nonresponse in Primary Care Treatment of Depression. https://app.cochat.ai/papers/10.1001/archinte.164.11.1197
- The paper
- Corey-Lisle, P. K., Nash, R., Stang, P., & Swindle, R. (2004). Response, Partial Response, and Nonresponse in Primary Care Treatment of Depression. Archives of Internal Medicine. https://doi.org/10.1001/archinte.164.11.1197
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.